Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management (under the brand name Zepbound)
References: About The Author Dr
Drug Interactions Cytochrome P450-Metabolized Drugs Co-administration of tesamorelin with simvastatin, a sensitive CYP3A substrate, showed that tesamorelin had no significant impact on the pharmacokinetics profiles of simvastatin in healthy subjects
Begin Wegovy first, allow 48 weeks for adaptation, then discuss Lipo C with your doctor if needed
JCI Insight [Internet]
US$ 29.31
US$ 22.10
US$ 23.67
US$ 21.62
US$ 21.63
US$ 21.46
US$ 27.46
